“We are interested in the usage of this and associated molecules to manage chronic pain in the clinic. Of course, the curiosity is in using the compounds by themselves, given that they don't generate the sedation characteristic of dexmedetomidine, which is a good drug, but one that is essentially https://bookmarkextent.com/story17998705/a-review-of-the-new-pain-kille-conolidine